Enlist the anti- parasitic drug. Describe the adverse effect of parasitic drug?
| Drug | Class | Use |
|---|---|---|
| Chloroquine | 4-aminoquinoline | Malaria prophylaxis/treatment (P. vivax, P. malariae) |
| Quinine / Quinidine | Cinchona alkaloid | Severe/complicated malaria |
| Mefloquine | 4-quinolinemethanol | Prophylaxis and treatment (chloroquine-resistant P. falciparum) |
| Primaquine | 8-aminoquinoline | Radical cure of P. vivax / P. ovale (kills liver hypnozoites) |
| Artemether-Lumefantrine (Coartem) | Artemisinin combination | First-line uncomplicated P. falciparum |
| Atovaquone-Proguanil (Malarone) | Antifolate combination | Prophylaxis and treatment |
| Doxycycline | Tetracycline antibiotic | Prophylaxis; adjunct in P. falciparum |
| Drug | Target Organism |
|---|---|
| Metronidazole / Tinidazole | Entamoeba histolytica, Giardia, Trichomonas |
| Nitazoxanide | Giardia, Cryptosporidium, E. histolytica |
| Paromomycin | Intestinal amebiasis; Leishmaniasis |
| Miltefosine | Visceral leishmaniasis |
| Sodium stibogluconate | Leishmaniasis (first-line in many regions) |
| Pentamidine | African trypanosomiasis; Pneumocystis |
| Suramin | African trypanosomiasis (early stage) |
| Melarsoprol | African trypanosomiasis (late stage, CNS) |
| Eflornithine | African sleeping sickness (T. b. gambiense) |
| Nifurtimox | Chagas disease (T. cruzi) |
| Benznidazole | Chagas disease (drug of choice in endemic countries) |
| Fexinidazole | African trypanosomiasis |
| Amphotericin B (liposomal) | Visceral leishmaniasis (antimonial-resistant) |
| Pyrimethamine | Toxoplasmosis (+ sulfadiazine) |
| Trimethoprim-Sulfamethoxazole | Pneumocystis jirovecii pneumonia (PCP) |

| Drug | Use |
|---|---|
| Mebendazole | Trichuris, Enterobius, hookworms, Ascaris |
| Albendazole | Broad-spectrum; STHs, larva migrans, cysticercosis |
| Ivermectin | Onchocerciasis, strongyloidiasis, scabies, lice |
| Pyrantel pamoate | Pinworms, hookworms |
| Diethylcarbamazine (DEC) | Lymphatic filariasis, tropical eosinophilia |
| Moxidectin | Onchocerciasis |
| Drug | Use |
|---|---|
| Praziquantel | Schistosomiasis, liver flukes, most trematodes |
| Triclabendazole | Fasciola hepatica/gigantica (liver flukes) |
| Drug | Use |
|---|---|
| Praziquantel | Taeniasis, neurocysticercosis |
| Albendazole | Neurocysticercosis, echinococcosis |
| Niclosamide | Taeniasis, diphyllobothriasis (not available in US) |
| Drug | Minor Toxicity | Major Toxicity | Special Notes |
|---|---|---|---|
| Chloroquine | Nausea, vomiting, diarrhea, pruritus, postural hypotension, headache, dizziness | Retinopathy (prolonged use); hypotension/shock (parenteral) | Avoid in psoriasis, porphyria |
| Quinine / Quinidine | Cinchonism: tinnitus, headache, nausea, dizziness, visual disturbance | Cardiac dysrhythmias, hypotension, hypoglycemia, Coombs-positive hemolysis, neuromuscular paralysis | Contraindicated in cardiac disease |
| Mefloquine | Nausea, cramps, diarrhea, nightmares, bradycardia | Acute toxic confusional states, seizures, cardiac dysrhythmias | Avoid in neuropsychiatric disorders, seizure history |
| Primaquine | Nausea, vomiting, diarrhea, methemoglobinemia | Massive hemolytic anemia in G6PD deficiency; SLE/RA exacerbation | Contraindicated in G6PD deficiency and pregnancy |
| Doxycycline | GI disturbances, photosensitivity, vaginal candidiasis | Esophageal ulceration | Avoid in pregnancy and children <8 years |
| Artemether-Lumefantrine | Headache, dizziness, anorexia, asthenia | QT prolongation, severe skin rash | Avoid with other QT-prolonging drugs |
| Atovaquone-Proguanil | Nausea, vomiting, oral ulcers, headaches | Serious allergic reactions, alopecia | Contraindicated in pregnancy, CrCl <30 mL/min |
| Drug Category | Key Adverse Effect to Remember |
|---|---|
| Chloroquine | Retinopathy (chronic), pruritus |
| Quinine | Cinchonism, hypoglycemia, cardiac arrhythmia |
| Primaquine | Hemolysis in G6PD deficiency |
| Mefloquine | Neuropsychiatric effects, nightmares |
| Metronidazole | Metallic taste, disulfiram-alcohol reaction |
| Nifurtimox | Polyneuritis, GI toxicity |
| Melarsoprol | Post-treatment reactive encephalopathy (fatal) |
| Pentamidine | Hypoglycemia, nephrotoxicity, QT prolongation |
| Ivermectin | Mazzotti reaction |
| Mebendazole | Stevens-Johnson with metronidazole |
| Praziquantel | Drug interactions via CYP3A4 |
| Albendazole | Hepatotoxicity (prolonged use), teratogen |